Primary care physicians' attitudes related to cognition enhancers in early dementia: A representative eight-year follow-up study in Lower Saxony, Germany

International Journal of Geriatric Psychiatry

Volumn 23, Issue 4, 2008, Pages 415-421

  Maeck, Lienhard ^a   Haak, Sebastian ^b   Knoblauch, Anita ^c   Stoppe, Gabriela ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b KLINIKUM OLDENBURG   (Germany)

^c Niedersächsisches Landeskrankenhaus   (Germany)

Author keywords

Alzheimer's disease; Antidementia drug treatment; Cholinesterase inhibitors; Primary care

Indexed keywords

CHOLINESTERASE INHIBITOR; GINKGO BILOBA EXTRACT; MEMANTINE; NIMODIPINE; NOOTROPIC AGENT; PENTOXIFYLLINE; PIRACETAM;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GERMANY; HUMAN; MALE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW;

ATTITUDE OF HEALTH PERSONNEL; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; NOOTROPIC AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY;

EID: 42449119821     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1896     Document Type: Article

References (34)

1. Bickel H. 2001. Dementia in advanced age: estimating incidence and health care costs. Z Gerontol Geriatr 34: 108-115.
2. Birks J. 2006. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1: 11.
3. Birks J, Grimley EJ. 2007. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Sys Rev 2: 9.
4. Boise L, Neal MB, Kaye J. 2004. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol A Biol Sci Med Sci 59: 621-626.
5. Boustani M, Callahan CM, Unverzagt FW, et al. 2005. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med 20: 572-577.
6. Cody M, Beck C, Shue VM, Pope S. 2002. Reported practices of primary care physicians in the diagnosis and management of dementia. Aging Ment Health 6: 72-76.
7. Courtney C, Farrell D, Gray R, et al. and the AD 2000 Collaborative Group. 2004. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363: 2105-2115.
8. DeKosky ST, Fitzpatrick A, Ives DG, et al. and the GEMS Investigators. 2006. The Ginkgo Evaluation of Memory (GEM) study. Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 27: 238-253.
9. Diehl J, Staehelin H, Wiltfang J, et al. 2003. German-speaking memory clinics: state of the art and practical recommendations. Z Gerontol Geriatr 36: 289-296.
10. Geldmacher DS, Provenzano G, McRae T, et al. 2003. Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc 51: 937-944.
11. Holt WS, Mazzucca SA. 1992. A written case simulation of osteoarthritis as a predictor of prescribing behaviour among family practitioners. Acad Med 67: 414-415.
12. Iliffe S, Manthorpe J, Eden A. 2003. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract 20: 376-381.
13. Löppönen MK, Isoaho RE, Raiha IJ, et al. 2004. Undiagnosed diseases in patients with dementia - a potential target group for intervention. Dement Geriatr Cogn Disord 18: 321-329.
14. Lehrner J, Gufler R. Guttmann G, et al. 2005. Annual conversion to Alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing. Wien Klin Wochenschr 117: 629-635.
15. Maeck L, Haak S, Knoblauch A, Stoppe G. 2007. Early diagnosis of dementia in primary care: a representative eight-year follow-up study in Lower Saxony, Germany. Int J Geriatr Psychiatry 22: 23-31.
16. Mayer KU, Baltes PB (eds). 1996. The Berlin Aging Study. Akademie Verlag: Berlin.
17. Müller U, Wolf H, Kiefer M, Gertz H-J. 2003. A systematic comparison of national and international dementia guidelines. Fortsch Neurol Psychiat 71: 285-295.
18. Ngatcha-Ribert L. 2004. Alzheimer disease and society: an analysis of its social representation. Psychol Neuropsychiatr Vieil 2: 49-66.
19. Olafsdottir M, Foldevi M, Marcusson J. 2001. Dementia in primary care: why the low detection rate? Scand J Prim Health Care 19: 194-198.
20. Riedel-Heller SG, Schork A, Matschinger H, Angermeyer MC. 1999. The role of referrals in diagnosing dementia at the primary care level. Int Psychogeriatr 11: 251-262.
21. Schneider LS, DeKosky ST, Farlow MR, et al. 2005. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2: 541-545.
22. Small GW, Rabins PV, Barry PP, et al. 1997. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278: 1363-1371.
23. Stoppe G, Pirk O, Haupt M. 2005. Treatment of Alzheimer's disease utilising the best available evidence-based medicine - Utopia? Gesundheitswesen 67: 20-26.
24. Stoppe G, Bergmann F, Bohlken J, et al. 2004. Outpatient care for the demented: a proposal for the cooperation of family physicians and neuro-psychiatrists in Germany. Psychoneuro 30: 489-496.
25. Stoppe G, Pirk O. 2002. Praxisstudie: therapie von Alzheimer-patienten. Der Allgemeinarzt 12: 884-886.
26. Stoppe G, Sandholzer H, Huppertz C, et al. 1999. Gender differences in the recognition of depression in old age. Maturitas 32: 205-212.
27. Stoppe G, Sandholzer H, Staedt J, et al. 1995. Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in Lower Saxony, Germany. Int J Clin Pharmacol Ther 33: 486-490.
28. Stoppe G, Sandholzer H, Staedt J, et al. 1994. Diagnosis of dementia in primary care: results of a representative study in Lower Saxony, Germany. Eur Arch Psychiatry Clin Neurosci 244: 278-283.
29. Turner S, Iliffe S, Downs M, et al. 2004. General practitioners' knowledge, confidence and attitudes in the diagnosis and management of dementia. Age Ageing 33: 461-467.
30. van den Bussche H. 2005. Problems and questions of pharmacological therapy of Alzheimer's disease with cholinesterase inhibitors. Z Gerontol Geriat 38(Suppl 1): I/18-I/20.
31. van den Bussche H, Kaduszkiewicz H. 2005. Prescription patterns and effectiveness perception of anti-dementia drugs - a comparison between General Practitioners, Neurologists and Psychiatrists. Nervenheilkunde 6: 485-492.
32. van Hout H, Vernooij-Dassen M, Bakker K, et al. 2000. General practitioners on dementia: tasks, practices and obstacles. Patient Educ Couns 39: 219-225.
33. Waldorff FB, Almind G, Makela M, et al. 2003. Implementation of a clinical dementia guideline. A controlled study on the effect of a multifaceted strategy. Scand J Print Health Care 21: 142-147.
34. World Health Organisation (VIFHO). 1991. Tenth Revision of the International Classification of Diseases. WHO: Geneva.